Zevra Therapeutics, Inc. ZVRA Consulting fees paid in common stock
Consulting fees paid in common stock at other companies
Other financials
Where this comes from
Reported directly by Zevra Therapeutics, Inc. in its filing.
Tagged under the XBRL concept zvra:ConsultingFeesPaidInCommonStock.
The official record: Zevra Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Zevra Therapeutics, Inc.'s consulting fees paid in common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Zevra Therapeutics, Inc.'s consulting fees paid in common stock?
- Zevra Therapeutics, Inc. (ZVRA) reported consulting fees paid in common stock of $0 in Q1 2026.
- What does consulting fees paid in common stock mean?
- Represents the value of services rendered by consultants that are settled through the issuance of equity rather than cash. This metric is important for understanding non-cash operating expenses and the potential dilutive impact of compensating service providers with stock.